Benefit Sharing by Doris Schroeder & Julie Cook Lucas

Author:Doris Schroeder & Julie Cook Lucas
Language: eng
Format: epub
Publisher: Springer Netherlands, Dordrecht

Representation issues in benefit sharing negotiations/agreements

The fear of undue inducement or problems with informed consent

Export of samples.

5.3.5.1 Appropriate Benefits and Representation Issues

Benefit sharing in the context of the CBD is often assumed to mean monetary royalties from marketed products. Benefit sharing in the case of post-study obligations in medical research is normally assumed to mean access to marketed products. Yet, in both areas, alternative benefits are feasible. Under the CBD, benefits are usually negotiated case by case. Hence there are no legal requirements for any particular kind of benefit: outcomes depend on the particular negotiations. Likewise, the Declaration of Helsinki and similar guidelines recognize that in some cases alternative benefits might be more appropriate than access to successfully tested health interventions; otherwise research participants involved in studies, such as those in Majengo, which do not lead directly to a particular product or intervention would simply not benefit at all (see also Chap.​ 8).

The following list (which is not exhaustive) gives examples of benefits which satisfy current standard benefit-sharing requirements in addition to royalties (CBD context) and straightforward post-study access to products:Feedback to participants (Declaration of Helsinki) (WMA 2008: article 33)

Download

Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.